Morphic Therapeutic Competitors and Similar CompaniesClear all
Morphic Therapeutic's competitors and similar companies include Alzheon and Transition Bio.
 Alzheon Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. |  Transition Bio Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis. | ||
Founding Date | Founding Date 2015 | Founding Date 2013 | Founding Date 2020 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Waltham, US HQ | Locations Framingham, US HQ | Locations Cambridge, US HQ Cambridge, GB |
Employees | Employees 76 | Employees 3310% increase | Employees 2915% decrease |
Financial | |||
Net income | Net income ($152.1m) (FY, 2023) | Net income ($5.5m) (FY, 2017) | Net income N/A |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 15.8m (almost 9 years ago) | Latest funding round $ 50m (about 4 years ago) |
Total funding raised | Total funding raised $ 131.5m | Total funding raised $ 37.1m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Alzheon
HQ
Framingham, US
Employees
33↑ 10% increase
Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
View companyTransition Bio
HQ
Cambridge, US
Employees
29↓ 15% decrease
Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis.
View company